Acro Biomedical (ACBM) Invested Capital (2016 - 2025)
Acro Biomedical (ACBM) has 10 years of Invested Capital data on record, last reported at -$386964.0 in Q4 2025.
- For Q4 2025, Invested Capital fell 31.19% year-over-year to -$386964.0; the TTM value through Dec 2025 reached -$386964.0, down 31.19%, while the annual FY2025 figure was -$386964.0, 31.19% down from the prior year.
- Invested Capital reached -$386964.0 in Q4 2025 per ACBM's latest filing, up from -$432619.0 in the prior quarter.
- Across five years, Invested Capital topped out at $886444.0 in Q1 2021 and bottomed at -$432619.0 in Q3 2025.
- Average Invested Capital over 5 years is $143998.4, with a median of $50020.5 recorded in 2023.
- Peak YoY movement for Invested Capital: dropped 2.91% in 2022, then plummeted 181.38% in 2024.
- A 5-year view of Invested Capital shows it stood at $664448.0 in 2021, then decreased by 14.94% to $565196.0 in 2022, then plummeted by 145.47% to -$257014.0 in 2023, then dropped by 14.77% to -$294972.0 in 2024, then tumbled by 31.19% to -$386964.0 in 2025.
- Per Business Quant database, its latest 3 readings for Invested Capital were -$386964.0 in Q4 2025, -$432619.0 in Q3 2025, and -$317520.0 in Q2 2025.